Global Chronic Kidney Disease (CKD) Drugs Market Growth 2020-2025
According to this study, over the next five years the Chronic Kidney Disease (CKD) Drugs market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Chronic Kidney Disease (CKD) Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Kidney Disease (CKD) Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Chronic Kidney Disease (CKD) Drugs, covering the supply chain analysis, impact assessment to the Chronic Kidney Disease (CKD) Drugs market size growth rate in several scenarios, and the measures to be undertaken by Chronic Kidney Disease (CKD) Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
ACE Inhibitors
Angiotensin-II Receptor Blockers
Calcium Channel Blockers
Beta Blockers: BREVIBLOC, Bystolic
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Specialty Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer, Inc.
Amgen
GlaxoSmithKline (GSK)
Allergan
Roche
AbbVie
Kissei Pharmaceutical Co., Ltd.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Chronic Kidney Disease (CKD) Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Chronic Kidney Disease (CKD) Drugs market by identifying its various subsegments.
Focuses on the key global Chronic Kidney Disease (CKD) Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Chronic Kidney Disease (CKD) Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Chronic Kidney Disease (CKD) Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chronic Kidney Disease (CKD) Drugs Consumption 2015-2025
2.1.2 Chronic Kidney Disease (CKD) Drugs Consumption CAGR by Region
2.2 Chronic Kidney Disease (CKD) Drugs Segment by Type
2.2.1 ACE Inhibitors
2.2.2 Angiotensin-II Receptor Blockers
2.2.3 Calcium Channel Blockers
2.2.4 Beta Blockers: BREVIBLOC, Bystolic
2.2.5 Others
2.3 Chronic Kidney Disease (CKD) Drugs Consumption by Type
2.3.1 Global Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Chronic Kidney Disease (CKD) Drugs Sale Price by Type (2015-2020)
2.4 Chronic Kidney Disease (CKD) Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.5 Chronic Kidney Disease (CKD) Drugs Consumption by Application
2.5.1 Global Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Chronic Kidney Disease (CKD) Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Chronic Kidney Disease (CKD) Drugs Sale Price by Type (2015-2020)
3 Global Chronic Kidney Disease (CKD) Drugs by Company
3.1 Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Company
3.1.1 Global Chronic Kidney Disease (CKD) Drugs Sales by Company (2018-2020)
3.1.2 Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Company (2018-2020)
3.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Company
3.2.1 Global Chronic Kidney Disease (CKD) Drugs Revenue by Company (2018-2020)
3.2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Chronic Kidney Disease (CKD) Drugs Sale Price by Company
3.4 Global Chronic Kidney Disease (CKD) Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Chronic Kidney Disease (CKD) Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Chronic Kidney Disease (CKD) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Chronic Kidney Disease (CKD) Drugs by Regions
4.1 Chronic Kidney Disease (CKD) Drugs by Regions
4.2 Americas Chronic Kidney Disease (CKD) Drugs Consumption Growth
4.3 APAC Chronic Kidney Disease (CKD) Drugs Consumption Growth
4.4 Europe Chronic Kidney Disease (CKD) Drugs Consumption Growth
4.5 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption Growth
5 Americas
5.1 Americas Chronic Kidney Disease (CKD) Drugs Consumption by Countries
5.1.1 Americas Chronic Kidney Disease (CKD) Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Chronic Kidney Disease (CKD) Drugs Value by Countries (2015-2020)
5.2 Americas Chronic Kidney Disease (CKD) Drugs Consumption by Type
5.3 Americas Chronic Kidney Disease (CKD) Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Chronic Kidney Disease (CKD) Drugs Consumption by Regions
6.1.1 APAC Chronic Kidney Disease (CKD) Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Chronic Kidney Disease (CKD) Drugs Value by Regions (2015-2020)
6.2 APAC Chronic Kidney Disease (CKD) Drugs Consumption by Type
6.3 APAC Chronic Kidney Disease (CKD) Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Chronic Kidney Disease (CKD) Drugs by Countries
7.1.1 Europe Chronic Kidney Disease (CKD) Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Chronic Kidney Disease (CKD) Drugs Value by Countries (2015-2020)
7.2 Europe Chronic Kidney Disease (CKD) Drugs Consumption by Type
7.3 Europe Chronic Kidney Disease (CKD) Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Chronic Kidney Disease (CKD) Drugs by Countries
8.1.1 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption by Type
8.3 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Chronic Kidney Disease (CKD) Drugs Distributors
10.3 Chronic Kidney Disease (CKD) Drugs Customer
11 Global Chronic Kidney Disease (CKD) Drugs Market Forecast
11.1 Global Chronic Kidney Disease (CKD) Drugs Consumption Forecast (2021-2025)
11.2 Global Chronic Kidney Disease (CKD) Drugs Forecast by Regions
11.2.1 Global Chronic Kidney Disease (CKD) Drugs Forecast by Regions (2021-2025)
11.2.2 Global Chronic Kidney Disease (CKD) Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Chronic Kidney Disease (CKD) Drugs Forecast by Type
11.8 Global Chronic Kidney Disease (CKD) Drugs Forecast by Application
12 Key Players Analysis
12.1 Pfizer, Inc.
12.1.1 Company Information
12.1.2 Chronic Kidney Disease (CKD) Drugs Product Offered
12.1.3 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer, Inc. Latest Developments
12.2 Amgen
12.2.1 Company Information
12.2.2 Chronic Kidney Disease (CKD) Drugs Product Offered
12.2.3 Amgen Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Amgen Latest Developments
12.3 GlaxoSmithKline (GSK)
12.3.1 Company Information
12.3.2 Chronic Kidney Disease (CKD) Drugs Product Offered
12.3.3 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 GlaxoSmithKline (GSK) Latest Developments
12.4 Allergan
12.4.1 Company Information
12.4.2 Chronic Kidney Disease (CKD) Drugs Product Offered
12.4.3 Allergan Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Allergan Latest Developments
12.5 Roche
12.5.1 Company Information
12.5.2 Chronic Kidney Disease (CKD) Drugs Product Offered
12.5.3 Roche Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Roche Latest Developments
12.6 AbbVie
12.6.1 Company Information
12.6.2 Chronic Kidney Disease (CKD) Drugs Product Offered
12.6.3 AbbVie Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 AbbVie Latest Developments
12.7 Kissei Pharmaceutical Co., Ltd.
12.7.1 Company Information
12.7.2 Chronic Kidney Disease (CKD) Drugs Product Offered
12.7.3 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Kissei Pharmaceutical Co., Ltd. Latest Developments
...
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Chronic Kidney Disease (CKD) Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of ACE Inhibitors
Table 5. Major Players of Angiotensin-II Receptor Blockers
Table 6. Major Players of Calcium Channel Blockers
Table 7. Major Players of Beta Blockers: BREVIBLOC, Bystolic
Table 8. Major Players of Others
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Type (2015-2020)
Table 11. Global Chronic Kidney Disease (CKD) Drugs Revenue by Type (2015-2020) ($ million)
Table 12. Global Chronic Kidney Disease (CKD) Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Chronic Kidney Disease (CKD) Drugs Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Application (2015-2020)
Table 16. Global Chronic Kidney Disease (CKD) Drugs Value by Application (2015-2020)
Table 17. Global Chronic Kidney Disease (CKD) Drugs Value Market Share by Application (2015-2020)
Table 18. Global Chronic Kidney Disease (CKD) Drugs Sale Price by Application (2015-2020)
Table 19. Global Chronic Kidney Disease (CKD) Drugs Sales by Company (2017-2019) (K Units)
Table 20. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Company (2017-2019)
Table 21. Global Chronic Kidney Disease (CKD) Drugs Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Company (2017-2019)
Table 23. Global Chronic Kidney Disease (CKD) Drugs Sale Price by Company (2017-2019)
Table 24. Global Chronic Kidney Disease (CKD) Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Chronic Kidney Disease (CKD) Drugs Products Offered
Table 26. Chronic Kidney Disease (CKD) Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Chronic Kidney Disease (CKD) Drugs Consumption by Regions 2015-2020 (K Units)
Table 28. Global Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Regions 2015-2020
Table 29. Global Chronic Kidney Disease (CKD) Drugs Value by Regions 2015-2020 ($ Millions)
Table 30. Global Chronic Kidney Disease (CKD) Drugs Value Market Share by Regions 2015-2020
Table 31. Americas Chronic Kidney Disease (CKD) Drugs Consumption by Countries (2015-2020) (K Units)
Table 32. Americas Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Countries (2015-2020)
Table 33. Americas Chronic Kidney Disease (CKD) Drugs Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Chronic Kidney Disease (CKD) Drugs Value Market Share by Countries (2015-2020)
Table 35. Americas Chronic Kidney Disease (CKD) Drugs Consumption by Type (2015-2020) (K Units)
Table 36. Americas Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Type (2015-2020)
Table 37. Americas Chronic Kidney Disease (CKD) Drugs Consumption by Application (2015-2020) (K Units)
Table 38. Americas Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Application (2015-2020)
Table 39. APAC Chronic Kidney Disease (CKD) Drugs Consumption by Regions (2015-2020) (K Units)
Table 40. APAC Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Regions (2015-2020)
Table 41. APAC Chronic Kidney Disease (CKD) Drugs Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Chronic Kidney Disease (CKD) Drugs Value Market Share by Regions (2015-2020)
Table 43. APAC Chronic Kidney Disease (CKD) Drugs Consumption by Type (2015-2020) (K Units)
Table 44. APAC Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Type (2015-2020)
Table 45. APAC Chronic Kidney Disease (CKD) Drugs Consumption by Application (2015-2020) (K Units)
Table 46. APAC Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Application (2015-2020)
Table 47. Europe Chronic Kidney Disease (CKD) Drugs Consumption by Countries (2015-2020) (K Units)
Table 48. Europe Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Countries (2015-2020)
Table 49. Europe Chronic Kidney Disease (CKD) Drugs Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Chronic Kidney Disease (CKD) Drugs Value Market Share by Countries (2015-2020)
Table 51. Europe Chronic Kidney Disease (CKD) Drugs Consumption by Type (2015-2020) (K Units)
Table 52. Europe Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Type (2015-2020)
Table 53. Europe Chronic Kidney Disease (CKD) Drugs Consumption by Application (2015-2020) (K Units)
Table 54. Europe Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption by Countries (2015-2020) (K Units)
Table 56. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption by Type (2015-2020) (K Units)
Table 60. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption by Application (2015-2020) (K Units)
Table 62. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Application (2015-2020)
Table 63. Chronic Kidney Disease (CKD) Drugs Distributors List
Table 64. Chronic Kidney Disease (CKD) Drugs Customer List
Table 65. Global Chronic Kidney Disease (CKD) Drugs Consumption Forecast by Countries (2021-2025) (K Units)
Table 66. Global Chronic Kidney Disease (CKD) Drugs Consumption Market Forecast by Regions
Table 67. Global Chronic Kidney Disease (CKD) Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Chronic Kidney Disease (CKD) Drugs Value Market Share Forecast by Regions
Table 69. Global Chronic Kidney Disease (CKD) Drugs Consumption Forecast by Type (2021-2025) (K Units)
Table 70. Global Chronic Kidney Disease (CKD) Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Chronic Kidney Disease (CKD) Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Chronic Kidney Disease (CKD) Drugs Value Market Share Forecast by Type (2021-2025)
Table 73. Global Chronic Kidney Disease (CKD) Drugs Consumption Forecast by Application (2021-2025) (K Units)
Table 74. Global Chronic Kidney Disease (CKD) Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Chronic Kidney Disease (CKD) Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Chronic Kidney Disease (CKD) Drugs Value Market Share Forecast by Application (2021-2025)
Table 77. Pfizer, Inc. Product Offered
Table 78. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 79. Pfizer, Inc. Main Business
Table 80. Pfizer, Inc. Latest Developments
Table 81. Pfizer, Inc. Basic Information, Company Total Revenue (in $ million), Chronic Kidney Disease (CKD) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 82. Amgen Product Offered
Table 83. Amgen Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 84. Amgen Main Business
Table 85. Amgen Latest Developments
Table 86. Amgen Basic Information, Company Total Revenue (in $ million), Chronic Kidney Disease (CKD) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. GlaxoSmithKline (GSK) Product Offered
Table 88. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 89. GlaxoSmithKline (GSK) Main Business
Table 90. GlaxoSmithKline (GSK) Latest Developments
Table 91. GlaxoSmithKline (GSK) Basic Information, Company Total Revenue (in $ million), Chronic Kidney Disease (CKD) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. Allergan Product Offered
Table 93. Allergan Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 94. Allergan Main Business
Table 95. Allergan Latest Developments
Table 96. Allergan Basic Information, Company Total Revenue (in $ million), Chronic Kidney Disease (CKD) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Roche Product Offered
Table 98. Roche Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 99. Roche Main Business
Table 100. Roche Latest Developments
Table 101. Roche Basic Information, Company Total Revenue (in $ million), Chronic Kidney Disease (CKD) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. AbbVie Product Offered
Table 103. AbbVie Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 104. AbbVie Main Business
Table 105. AbbVie Latest Developments
Table 106. AbbVie Basic Information, Company Total Revenue (in $ million), Chronic Kidney Disease (CKD) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Kissei Pharmaceutical Co., Ltd. Product Offered
Table 108. Kissei Pharmaceutical Co., Ltd. Basic Information, Company Total Revenue (in $ million), Chronic Kidney Disease (CKD) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Kissei Pharmaceutical Co., Ltd. Main Business
Table 110. Kissei Pharmaceutical Co., Ltd. Latest Developments
Table 111. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
List of Figures
Figure 1. Picture of Chronic Kidney Disease (CKD) Drugs
Figure 2. Chronic Kidney Disease (CKD) Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Chronic Kidney Disease (CKD) Drugs Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Chronic Kidney Disease (CKD) Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of ACE Inhibitors
Figure 7. Product Picture of Angiotensin-II Receptor Blockers
Figure 8. Product Picture of Calcium Channel Blockers
Figure 9. Product Picture of Beta Blockers: BREVIBLOC, Bystolic
Figure 10. Product Picture of Others
Figure 11. Global Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Type (2015-2020)
Figure 12. Global Chronic Kidney Disease (CKD) Drugs Value Market Share by Type (2015-2020)
Figure 13. Chronic Kidney Disease (CKD) Drugs Consumed in Hospitals
Figure 14. Global Chronic Kidney Disease (CKD) Drugs Market: Hospitals (2015-2020) (K Units)
Figure 15. Global Chronic Kidney Disease (CKD) Drugs Market: Hospitals (2015-2020) ($ Millions)
Figure 16. Chronic Kidney Disease (CKD) Drugs Consumed in Specialty Clinics
Figure 17. Global Chronic Kidney Disease (CKD) Drugs Market: Specialty Clinics (2015-2020) (K Units)
Figure 18. Global Chronic Kidney Disease (CKD) Drugs Market: Specialty Clinics (2015-2020) ($ Millions)
Figure 19. Global Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Application (2015-2020)
Figure 20. Global Chronic Kidney Disease (CKD) Drugs Value Market Share by Application (2015-2020)
Figure 21. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Company in 2017
Figure 22. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Company in 2019
Figure 23. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Company in 2017
Figure 24. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Company in 2019
Figure 25. Global Chronic Kidney Disease (CKD) Drugs Sale Price by Company in 2019
Figure 26. Global Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Regions 2015-2020
Figure 27. Global Chronic Kidney Disease (CKD) Drugs Value Market Share by Regions 2015-2020
Figure 28. Americas Chronic Kidney Disease (CKD) Drugs Consumption 2015-2020 (K Units)
Figure 29. Americas Chronic Kidney Disease (CKD) Drugs Value 2015-2020 ($ Millions)
Figure 30. APAC Chronic Kidney Disease (CKD) Drugs Consumption 2015-2020 (K Units)
Figure 31. APAC Chronic Kidney Disease (CKD) Drugs Value 2015-2020 ($ Millions)
Figure 32. Europe Chronic Kidney Disease (CKD) Drugs Consumption 2015-2020 (K Units)
Figure 33. Europe Chronic Kidney Disease (CKD) Drugs Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Value 2015-2020 ($ Millions)
Figure 36. Americas Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Countries in 2019
Figure 37. Americas Chronic Kidney Disease (CKD) Drugs Value Market Share by Countries in 2019
Figure 38. Americas Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Type in 2019
Figure 39. Americas Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Application in 2019
Figure 40. United States Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 41. United States Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Countries in 2019
Figure 47. APAC Chronic Kidney Disease (CKD) Drugs Value Market Share by Regions in 2019
Figure 48. APAC Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Type in 2019
Figure 49. APAC Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Application in 2019
Figure 50. China Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 51. China Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 58. India Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 59. India Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Countries in 2019
Figure 63. Europe Chronic Kidney Disease (CKD) Drugs Value Market Share by Countries in 2019
Figure 64. Europe Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Type in 2019
Figure 65. Europe Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Application in 2019
Figure 66. Germany Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 68. France Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 69. France Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 70. UK Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 71. UK Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Application in 2019
Figure 80. Egypt Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Chronic Kidney Disease (CKD) Drugs Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Chronic Kidney Disease (CKD) Drugs Value Growth 2015-2020 ($ Millions)
Figure 90. Global Chronic Kidney Disease (CKD) Drugs Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Chronic Kidney Disease (CKD) Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 93. Americas Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 94. APAC Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 95. APAC Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 96. Europe Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 97. Europe Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 100. United States Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 101. United States Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 102. Canada Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 103. Canada Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 104. Mexico Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 105. Mexico Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 106. Brazil Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 107. Brazil Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 108. China Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 109. China Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 110. Japan Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 111. Japan Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 112. Korea Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 113. Korea Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 116. India Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 117. India Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 118. Australia Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 119. Australia Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 120. Germany Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 121. Germany Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 122. France Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 123. France Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 124. UK Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 125. UK Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 126. Italy Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 127. Italy Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 128. Russia Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 129. Russia Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 130. Spain Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 131. Spain Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 132. Egypt Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 133. Egypt Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 134. South Africa Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 135. South Africa Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 136. Israel Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 137. Israel Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 138. Turkey Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 139. Turkey Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Chronic Kidney Disease (CKD) Drugs Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Chronic Kidney Disease (CKD) Drugs Value 2021-2025 ($ Millions)
Figure 142. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Market Share (2018-2020)
Figure 143. Amgen Chronic Kidney Disease (CKD) Drugs Market Share (2018-2020)
Figure 144. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Market Share (2018-2020)
Figure 145. Allergan Chronic Kidney Disease (CKD) Drugs Market Share (2018-2020)
Figure 146. Roche Chronic Kidney Disease (CKD) Drugs Market Share (2018-2020)
Figure 147. AbbVie Chronic Kidney Disease (CKD) Drugs Market Share (2018-2020)
Figure 148. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets